(12) Patent Application Publication (10) Pub. No.: US 2011/0105825 A1 Nayfach-Battilana (43) Pub

Total Page:16

File Type:pdf, Size:1020Kb

(12) Patent Application Publication (10) Pub. No.: US 2011/0105825 A1 Nayfach-Battilana (43) Pub US 2011 01 05825A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2011/0105825 A1 Nayfach-Battilana (43) Pub. Date: May 5, 2011 (54) NANOPARTICLE-SIZED MAGNETIC (52) U.S. Cl. ............ 600/12: 424/9.3; 424/400; 424/450; ABSORPTION ENHANCERS HAVING 424/9.32; 977/904 THREE-DIMIENSIONAL GEOMETRIES ADAPTED FOR IMPROVED DAGNOSTICS AND HYPERTHERMIC TREATMENT (57) ABSTRACT Nanoparticle-sized magnetic absorption enhancers (MAES) (75) Inventor: Joseph N. Nayfach-Battilana, San that exhibit a controlled response to a magnetic field, includ Rafael, CA (US) ing a controlled mechanical response and inductive thermal response. The MAEs have a magnetic material that exhibits (73) Assignee: Qteris Inc. the inductive thermal response to the magnetic field and is (21) Appl. No.: 12/925,904 embedded in a coating, such that the MAE conforms to a particular shape, e.g., a hemisphere, a dome or a shell, that is (22) Filed: Nov. 1, 2010 chosen to produce the desired controlled mechanical response of the entire MAE to the magnetic field. A targeting Related U.S. Application Data moiety for specifically binding the MAE to a pathogen target is also provided. The MAEs are preferably bound by a flexible (60) Provisional application No. 61/256,986, filed on Oct. linker to promote the desired mechanical response, which 31, 2009. includes interactions between MAEs that are not bound to their pathogen target for the purpose of forming spheres, Publication Classification spherical shells, or generally spherical dimers. Such forms (51) Int. Cl. contain the thermal energy produced by the thermal inductive A6 IN 2/10 (2006.01) response of the magnetic material and thus reduce collateral A6 IK 49/00 (2006.01) healthy tissue damage during hyperthermic treatment. The A6 IK 9/00 (2006.01) inventing extends to appropriate apparatus and methods for A 6LX 9/27 (2006.01) diagnostics and hyperthermic treatments employing the A6IP3/04 (2006.01) MAES. Patent Application Publication May 5, 2011 Sheet 1 of 12 US 2011/O105825 A1 B 100 A. Z. ARIORAR2 Patent Application Publication May 5, 2011 Sheet 2 of 12 US 2011/O105825 A1 126 s Av. 25 ARIOR AR7) Patent Application Publication May 5, 2011 Sheet 3 of 12 US 2011/O105825 A1 Patent Application Publication May 5, 2011 Sheet 4 of 12 US 2011/O105825 A1 222 202D Patent Application Publication May 5, 2011 Sheet 5 of 12 US 2011/O105825 A1 Patent Application Publication May 5, 2011 Sheet 6 of 12 US 2011/O105825 A1 41 OB 41 OE 416D 41 OF 41 OD 410C 412B 422 410G 416G 418B 420 Patent Application Publication May 5, 2011 Sheet 7 of 12 US 2011/O105825 A1 Patent Application Publication May 5, 2011 Sheet 8 of 12 US 2011/0105825 A1 1. MAE Administration 901 2. Magnetic Resonance 902 Imaging of MAE 903 3. MAE Tissue Saturation Threshold CYES) 907 Reached? 4. Magnetic Dipole 7. Wait for Antibody Bio-Conjugation Recomputation and MAE Tissue Clearance 5. Magnetic Dipole 6. Magnetic Resonance 8. Magnetic Resonance Reorientation Imaging of MAE Imaging of MAE 905 906 908 9. Pathogen and MAE Location/Temperature 909 Map Distribution 911 11. Diagnosis Positive Treatment Recommended 910 913 13. Initial Device 10. MAE Tissue Configuration CYES) Saturation Threshold Maintained? 14. Apply Alternating 914 912 Magnetic Field Pulse 12. Diagnosis Negative Sequence (AMF) No Treatment Needed Treatment Halted 15. IR/Fluorescent 20. Device Re Imaging of MAE configuration Using New Parameters 920 16. Pathogen and MAE Location/Temperature Map Recomputation 17. Adapt AFM Pulse Sequence Parameters to Maximize MAE/ 18. Pathogen 19. Destruction Pathogen Thermal Transient, Treatment Without Exceeding Inflammatory Threshold Halted Response Threshold Reached? Patent Application Publication May 5, 2011 Sheet 9 of 12 US 2011/O105825 A1 a are - a a - a a A a Measure Pathogen.------------------------ Death Rate 1001 Get Temperature 1. Treatment Maps System Control 1004 4. NMR Thermometry Set AMF Parameters Get IR Raditiation Get IR Raditiation 5. Ambient Heat 3. MAE Heat 2. Magnetic Field Absorption Dissipation Generator 1005 Apply Magnetic OO Field Pulse 1002 v. ZO Patent Application Publication May 5, 2011 Sheet 10 of 12 US 2011/O105825 A1 700 708 s 7. Z25 Patent Application Publication May 5, 2011 Sheet 11 of 12 US 2011/O105825 A1 1 1i O 6 110 1108 1109 1110 Patent Application Publication May 5, 2011 Sheet 12 of 12 US 2011/O105825 A1 A. Z4 US 2011/O 105825 A1 May 5, 2011 NANOPARTICLE-SIZED MAGNETIC 0007 Examples of resistant organisms include Methicil ABSORPTION ENHANCERS HAVING lin-resistant Staphylococcus aureus (MRSA), Vancomycin THREE-DIMIENSIONAL GEOMETRIES resistant enterococci (VRE), multiple-drug-resistant Gram ADAPTED FOR IMPROVED DAGNOSTICS negative bacilli, penicillin-resistant Streptococcus AND HYPERTHERMIC TREATMENT pneumoniae, penicillin, tetracycline, and quinolone-resistant Neisseria gonorrhoeae, and multi-resistant Shigella, Salmo RELATED APPLICATIONS nella, and Campylobacter species. In fact, Vancomycin-resis tant enterococi (VRE), which emerged in the late 1980s, are 0001. This application claims priority from U.S. provi now endemic in many hospitals with a prevalence of more sional patent application 61/256,986 filed on 31 Oct. 2009 than 25% reported for intensive care units in the USA in 2000 and incorporated herein by reference. (National Nosocomial Infections Surveillance System report, 2001)VRE infections include urinary tract infections, bacter FIELD OF THE INVENTION aemia, edocarditis, and wound infections. 0008 Patients colonized with MRSA more frequently 0002 This invention relates generally to apparatus and develop systemic infections, including bacteremia, postster methods for diagnostics and hyperthermic treatments notomy media-stinitis, and Surgical site infections. Bacter employing nanoparticle-sized magnetic absorption enhanc emia caused by MRSA has been associated with significantly ers that attach to pathogen targets to be diagnosed or treated, higher mortality rates (29%-36%) than MRSSA (12-23%). and more specifically to three-dimensional geometries of The occurrence of MRSA in surgical site infections has a Such magnetic absorption enhancers that improve diagnostics significant impact on clinical and economic outcomes, nota and hyperthermic treatments. bly an increase in post-operative mortality. Mortality during the 90-day postoperative period was significantly higher in BACKGROUND ART patients with surgical site infections due to MRSA as com pared to patients with MSSA. Hospital costs were signifi General Review of Infectious Diseases and Develop cantly higher for patients with Surgical site infections due to ment of Pathogen Resistance to Current Treatments MRSA as compared with MSSA (p<0.001). (Reed, S. D., 0003. The development of new strains of pathogenic Friedman, J.Y., Engemann, J. J., Griffiths, R.I., Anstrom, K. microorganisms resistant to antimicrobial agents has become J., Kaye, K. S.) a serious risk to public health (G. C. Gemmel, “Glycopeptide 0009 Multi-drug resistant MRSA is now reported in a resistance in Staphylococcus aureus. is it a real threat?'. J. variety of settings in the United States, including communi Infec. Chemother., pp. 10:69-75, 2004, I. Chopra, “Staphylo ties and hospitals. In 2000 the National Nosocomial Infec coccus aureus. concerns, causes, and cures. Expert Rev. tions Surveillance system reported that more than 50% of Anti Infect. Ther. pp. 1:45-55, 2003). This increasing inci Staphylococcus aureus isolates collected from intensive care dence of resistant pathogens presents a serious treat to both units were resistant to methicillin (MRSA). 120,000 people military personnel and civilians alike. Patients suffering from were infected with MRSA in 2005, causing 19,000 deaths. resistant infections often experience increased duration and The cost to just treat MRSA infections in the United States severity of infection and rate of morbidity. can be conservatively estimated at 5 billion dollars annually. 0004 Antimicrobial resistance is a biological phenom The annual cost of treating Staphylococcus Aureus, which is enon where bacteria multiply in the presence of an antibiotic resistant to multiple drugs, can be estimated 1.5 billion dol given at a higher than therapeutic dose (WHO Global Strat lars. There have been reports of an association between egy for Containment of Antimicrobial Resistance, 2001). MRSA infections and major hospital care disruptions when Resistance can be described for an entire species of bacteria cohort isolation and unit closure must be undertaken to con or it may emerge in specific strains of Susceptible species. trol infection outbreaks. The threat of antimicrobial resis There are three stages to the development of resistance: pro tance is also related to bioterrorism. action, acquired response, and selection. 0010. Of particular concern is an increasing incidence of 0005. This resistance results from an interplay of genetics Vancomycin resistance, which has direct consequences on and phenotypic expression. Genetic resistance may be patient mortality (MRSA Initiative, Dept. of Veterans Affairs, acquired through genetic mutation and then propagated 2007, Sharon S. Rotun et al. 1999). Vancomycin, has now through a colony of pathogen cells through DNA transfer. become a commonly used therapy for MRSA, but recent Phenotypic expression can result in the inactivation of the studies show development of resistance to Vancomycin (Van drug (penicillin, chloramphenicaol), expulsion of the drug comycin-intermediate Staphylococcus aureus (VISA)). Iso from
Recommended publications
  • The Food Poisoning Toxins of Bacillus Cereus
    toxins Review The Food Poisoning Toxins of Bacillus cereus Richard Dietrich 1,†, Nadja Jessberger 1,*,†, Monika Ehling-Schulz 2 , Erwin Märtlbauer 1 and Per Einar Granum 3 1 Department of Veterinary Sciences, Faculty of Veterinary Medicine, Ludwig Maximilian University of Munich, Schönleutnerstr. 8, 85764 Oberschleißheim, Germany; [email protected] (R.D.); [email protected] (E.M.) 2 Department of Pathobiology, Functional Microbiology, Institute of Microbiology, University of Veterinary Medicine Vienna, 1210 Vienna, Austria; [email protected] 3 Department of Food Safety and Infection Biology, Faculty of Veterinary Medicine, Norwegian University of Life Sciences, P.O. Box 5003 NMBU, 1432 Ås, Norway; [email protected] * Correspondence: [email protected] † These authors have contributed equally to this work. Abstract: Bacillus cereus is a ubiquitous soil bacterium responsible for two types of food-associated gastrointestinal diseases. While the emetic type, a food intoxication, manifests in nausea and vomiting, food infections with enteropathogenic strains cause diarrhea and abdominal pain. Causative toxins are the cyclic dodecadepsipeptide cereulide, and the proteinaceous enterotoxins hemolysin BL (Hbl), nonhemolytic enterotoxin (Nhe) and cytotoxin K (CytK), respectively. This review covers the current knowledge on distribution and genetic organization of the toxin genes, as well as mechanisms of enterotoxin gene regulation and toxin secretion. In this context, the exceptionally high variability of toxin production between single strains is highlighted. In addition, the mode of action of the pore-forming enterotoxins and their effect on target cells is described in detail. The main focus of this review are the two tripartite enterotoxin complexes Hbl and Nhe, but the latest findings on cereulide and CytK are also presented, as well as methods for toxin detection, and the contribution of further putative virulence factors to the diarrheal disease.
    [Show full text]
  • APPENDIX H – Bibliography of ECOTOX Open Literature
    APPENDIX H – Bibliography of ECOTOX Open Literature Refresh from 2012 Accepted by ECOTOX and OPP Reference List 1. Abbott, J. D.; Bruton, B. D., and Patterson, C. L. Fungicidal Inhibition of Pollen Germination and Germ-Tube Elongation in Muskmelon. REPSOIL,ENV; 1991; 26, (5): 529-530. Notes: EcoReference No.: 63745 Chemical of Concern: BMY,CTN,CuOH,MZB 2. Abney, M. R.; Ruberson, J. R.; Herzog, G. A.; Kring, T. J.; Steinkraus, D. C., and Roberts, P. M. Rise and Fall of Cotton Aphid (Hemiptera: Aphididae) Populations in Southeastern Cotton Production Systems. GRO,POP. Department of Entomology, North Carolina State University, Raleigh, NC, USA. [email protected]//: SOIL,ENV; 2008; 101, (1): 23-35. Notes: EcoReference No.: 156197 Chemical of Concern: AZX,CTN,IMC 3. Al-Dosari, S. A.; Cranshaw, W. S., and Schweissing, F. C. Effects on Control of Onion Thrips from Co- Application of Onion Pesticides. POPENV; 1996; 21, (1): 49-54. Notes: EcoReference No.: 90255 Chemical of Concern: CTN,CYP,CuOH,LCYT,MLX,MMM,Maneb 4. Arts, G. H. P.; Belgers, J. D. M.; Hoekzema, C. H., and Thissen, J. T. N. M. Sensitivity of Submersed Freshwater Macrophytes and Endpoints in Laboratory Toxicity Tests. GROAQUA; 2008; 153, (1): 199-206. Notes: EcoReference No.: 108008 Chemical of Concern: ASM,CTN,FNZ,PCP 5. Aziz, T.; Habte, M., and Yuen, J. E. Inhibition of Mycorrhizal Symbiosis in Leucaena leucocephala by Chlorothalonil. BCM,GRO,POPSOIL,ENV; 1991; 131, (1): 47-52. Notes: EcoReference No.: 92163 Chemical of Concern: CTN 6. Babu, T. H. Effectiveness of Certain Chemicals and Fungicides on the Feeding Behaviour of House Sparrows.
    [Show full text]
  • Evaluation of the Individual and Combined Toxicity of Fumonisin Mycotoxins in Human Gastric Epithelial Cells
    International Journal of Molecular Sciences Article Evaluation of the Individual and Combined Toxicity of Fumonisin Mycotoxins in Human Gastric Epithelial Cells Song Yu, Bingxuan Jia, Na Liu, Dianzhen Yu and Aibo Wu * SIBS-UGENT-SJTU Joint Laboratory of Mycotoxin Research, CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China; [email protected] (S.Y.); [email protected] (B.J.); [email protected] (N.L.); [email protected] (D.Y.) * Correspondence: [email protected]; Tel.: +86-21-54920716 Received: 23 July 2020; Accepted: 14 August 2020; Published: 18 August 2020 Abstract: Fumonisin contaminates food and feed extensively throughout the world, causing chronic and acute toxicity in human and animals. Currently, studies on the toxicology of fumonisins mainly focus on fumonisin B1 (FB1). Considering that FB1, fumonisin B2 (FB2) and fumonisin B3 (FB3) could coexist in food and feed, a study regarding a single toxin, FB1, may not completely reflect the toxicity of fumonisin. The gastrointestinal tract is usually exposed to these dietary toxins. In our study, the human gastric epithelial cell line (GES-1) was used as in vitro model to evaluate the toxicity of fumonisin. Firstly, we found that they could cause a decrease in cell viability, and increase in membrane leakage, cell death and the induction of expression of markers for endoplasmic reticulum (ER) stress. Their toxicity potency rank is FB1 > FB2 >> FB3. The results also showed that the synergistic effect appeared in the combinations of FB1 + FB2 and FB1 + FB3.
    [Show full text]
  • English-Persian
    English-Persian English-Persian A abrachia (= abrachiatism) ﺑﯽ دﺳﺘﯽ ﻣﺎدرزاد abrachiatism ﺑﯽ ﺳﺮو دﺳﺘﯽ ﻣﺎدر زاد abrachiocephalia ﺁ. (A (= adenine ﺑﯽ ﺳﺮ و دﺳﺖ ﻣﺎدر زاد abrachiocephalus ﺁ. (A (= adenovirus ﺑﯽ دﺳﺖ ﻣﺎدر زاد abrachius زﻧﺠﻴﺮﻩ ﺁ. A chain اﺑﺮﯾﻦ abrin دﯼ.ان.اﯼ ﻧﻮع ﺁ. A form DNA اﺑﺴﻴﺰﯾﮏ اﺳﻴﺪ abscisic acid ﺁ.ﯾﮏ، اﯼ.وان. A I (= first meiotic ﭘﻴﮑﺮ anaphase) absolute configuration ﺑﻨﺪﯼ/ﮐﻨﻔﻴﮕﻮراﺳﻴﻮن/ﺁراﯾ ﺁ.دو، اﯼ.ﺗﻮ. A II (= second meiotic ش ﻣﻄﻠﻖ (anaphase ﺟﺬب ﮐﻨﻨﺪﮔﯽ، absorbance ﺟﺎﯾﮕﺎﻩ اﯼ.،ﭘﯽ. A,P site درﺁﺷﺎﻣﻨﺪﮔﯽ، اﺁ (aa (amino acid درﮐﺸﻴﺪﮔﯽ، ﻗﺎﺑﻠﻴﺖ ﺟﺬب اﯼ.اﯼ.ﺟﯽ. AAG (= acid ﺟﺬب، ﺟﺬب ﺳﻄﺤﯽ، alpha-glucosidase) absorption درﺁﺷﺎﻣﯽ، درﮐﺸﯽ، درون اﯼ.اﯼ.ﺗﯽ. (AAT (= alpha-antitrypsin ﺟﺬﺑﯽ اﯼ.اﯼ.وﯼ. AAV (= adeno-associated ﺁﺑﺰﯾﻢ، اﺑﺰاﯾﻢ virus) abzyme ﺁ.ث.، اﯼ.ﺳﯽ. (AC (= adenyl cyclase اﯼ.ﺑﯽ. (ab (= antibody ﺧﺎر ﺳﺮﮎ acanthella ﭘﻴﺸﺒﻴﻨﯽ ژن اب اﯾﻨﻴﺘﻴﻮ ab initio gene prediction ﺧﺎر ﺳﺮان acanthocephala اﻧﺘﻘﺎل دهﻨﺪﻩ اﯼ.ﺑﯽ.ﺳﯽ. ABC transporter =) acanthocephalan ﺟﻮرﻩ/وارﯾﺘﻪ/رﻗﻢ/ﺳﻮﯾﻪ Abelson strain of murine (acanthocephalus (ﻣﺮﺑﻮط ﺑﻪ ﺟﻮﻧﺪﮔﺎن) ﺧﺎر ﺳﺮ acanthocephalus ﺁﺑﻠﺴﻮﻧﯽ ﺧﺎر ﺳﺮﭼﻪ acanthor ﮐﺞ راهﯽ aberration ﺑﯽ ﻗﻠﺒﯽ ﻣﺎدر زاد acardia ﺗﻮﻟﻴﺪ ﺧﻮد ﺑﺨﻮد، ﺗﻮﻟﻴﺪ ﻣﺜﻞ abiogenesis ﺑﯽ ﻗﻠﺐ ﻣﺎدر زاد acardiac ﺧﻮد ﺑﻪ ﺧﻮدﯼ، ﻧﺎزﯾﺴﺖ (acardiacus (=acardiac زاﯾﯽ (acardius (=acardiac ﻏﻴﺮ ﺁﻟﯽ، ﻏﻴﺮ زﻧﺪﻩ، ﻧﺎزﯾﻮا abiotic ﮐﻨﻪ زدﮔﯽ acariasis ﺗﻨﺶ ﻋﻮاﻣﻞ ﻓﻴﺰﯾﮑﯽ ﻣﺤﻴﻂ، abiotic stress ﮐﻨﻪ ﺳﺎﻧﺎن acarina ﺗﻨﺶ اﺑﻴﻮﺗﻴﮏ ﮐﻨﻪ ﺳﺎن acarine اﯼ.ﺑﯽ.ال abl (=Abelson strain of ﮐﻨﻪ زدﮔﯽ (murine) acarinosis (= acariasis ﮐﻨﻪ زدﮔﯽ ﭘﻮﺳﺖ acarodermatitis اﯼ.ﺑﯽ.ال. ABL (=Abelson strain of ﮐﻨﻪ ﺗﺮﺳﯽ murine) acarophobia ﺑﻠﻮغ ﺷﺘﺎﺑﺪار/ﺗﺴﺮﯾﻊ ﺷﺪﻩ accelerated maturation ﻓﺮﺳﺎب، ﺳﺎﯾﺶ، ذوب ﯾﺦ ablation ﮔﻠﻮﺑﻮﻟﻴﻦ ﺷﺘﺎﺑﺪهﻨﺪﻩ/ﺗﺴﺮﯾﻊ accelerator globulin اﯼ.ﺑﯽ.او.
    [Show full text]
  • How Bacillus Thuringiensishas
    Review TRENDS in Genetics Vol.17 No.4 April 2001 193 How Bacillus thuringiensis has evolved specific toxins to colonize the insect world Ruud A. de Maagd, Alejandra Bravo and Neil Crickmore Bacillus thuringiensis is a bacterium of great agronomic and scientific interest. between different strains has been observed both in a Together the subspecies of this bacterium colonize and kill a large variety of soil environment and within insects2. host insects and even nematodes, but each strain does so with a high degree of Individual Cry toxins have a defined spectrum of specificity. This is mainly determined by the arsenal of crystal proteins that the insecticidal activity, usually restricted to a few bacterium produces during sporulation. Here we describe the properties of species within one particular order of insects. To date, these toxin proteins and the current knowledge of the basis for their specificity. toxins for insect species in the orders Lepidoptera Assessment of phylogenetic relationships of the three domains of the active (butterflies and moths), Diptera (flies and toxin and experimental results indicate how sequence divergence in mosquitoes), Coleoptera (beetles and weevils) and combination with domain swapping by homologous recombination might Hymenoptera (wasps and bees) have been identified. have caused this extensive range of specificities. A small minority of crystal toxins shows activity against non-insect species such as nematodes3. A few Bacillus thuringiensis (Bt) is an endospore-forming toxins have an activity spectrum that spans two or bacterium characterized by the presence of a protein three insect orders – most notably Cry1Ba, which is crystal within the cytoplasm of the sporulating cell active against larvae of moths, flies and beetles4.
    [Show full text]
  • Role of Toxin Activation on Binding and Pore Formation Activity of the Bacillus Thuringiensis Cry3 Toxins in Membranes of Leptinotarsa Decemlineata (Say)
    Biochimica et Biophysica Acta 1660 (2004) 99–105 www.bba-direct.com Role of toxin activation on binding and pore formation activity of the Bacillus thuringiensis Cry3 toxins in membranes of Leptinotarsa decemlineata (Say) C. Rausella,1, I. Garcı´a-Roblesb,1,J.Sa´ncheza, C. Mun˜oz-Garaya, A.C. Martı´nez-Ramı´rezb, M.D. Realb, A. Bravoa,* a Instituto de Biotecnologı´a, Universidad Nacional Auto´noma de Me´xico, Ap. Postal 510-3, Cuernavaca 62250, Morelos, Mexico b Facultad de Ciencias Biolo´gicas, Universidad de Valencia, Dr. Moliner 50, Burjassot 46100, Valencia, Spain Received 29 July 2003; received in revised form 5 November 2003; accepted 7 November 2003 Abstract Binding and pore formation constitute key steps in the mode of action of Bacillus thuringiensis y-endotoxins. In this work, we present a comparative analysis of toxin-binding capacities of proteolytically processed Cry3A, Cry3B and Cry3C toxins to brush border membranes (BBMV) of the Colorado potato beetle Leptinotarsa decemlineata (CPB), a major potato coleopteran-insect pest. Competition experiments showed that the three Cry3 proteolytically activated toxins share a common binding site. Also heterologous competition experiments showed that Cry3Aa and Cry3Ca toxins have an extra binding site that is not shared with Cry3Ba toxin. The pore formation activity of the three different Cry3 toxins is analysed. High pore-formation activities were observed in Cry3 toxins obtained by proteolytical activation with CPB BBMV in contrast to toxins activated with either trypsin or chymotrypsin proteases. The pore-formation activity correlated with the formation of soluble oligomeric structures. Our data support that, similarly to the Cry1A toxins, the Cry3 oligomer is formed after receptor binding and before membrane insertion, forming a pre-pore structure that is insertion-competent.
    [Show full text]
  • Single Kernel Analysis of Fumonisins and Other Fungal Metabolites In
    Single kernel analysis of fumonisins and other fungal metabolites in maize from South African subsistence farmers Jesper Mølgaard Mogensen, Stine Mørcholdt Sørensen, Michael Sulyok, Liana van der Westhuizen, Gordon Shephard, Jens Christian Frisvad, Ulf Thrane, Rudolf Krska, Kristian Fog Nielsen To cite this version: Jesper Mølgaard Mogensen, Stine Mørcholdt Sørensen, Michael Sulyok, Liana van der Westhuizen, Gordon Shephard, et al.. Single kernel analysis of fumonisins and other fungal metabolites in maize from South African subsistence farmers. Food Additives and Contaminants, 2011, pp.1. 10.1080/19440049.2011.611823. hal-00744827 HAL Id: hal-00744827 https://hal.archives-ouvertes.fr/hal-00744827 Submitted on 24 Oct 2012 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Food Additives and Contaminants For Peer Review Only Single kernel analysis of fumonisins and other fungal metabolites in maize from South African subsistence farmers Journal: Food Additives and Contaminants Manuscript ID: TFAC-2011-122.R2 Manuscript Type: Original Research Paper Date
    [Show full text]
  • Bt Toxin Modification for Enhanced Efficacy
    Toxins 2014, 6, 3005-3027; doi:10.3390/toxins6103005 OPEN ACCESS toxins ISSN 2072-6651 www.mdpi.com/journal/toxins Review Bt Toxin Modification for Enhanced Efficacy Benjamin R. Deist 1, Michael A. Rausch 1, Maria Teresa Fernandez-Luna 1, Michael J. Adang 2,3 and Bryony C. Bonning 1,* 1 Department of Entomology, Iowa State University, Ames, IA 50011, USA; E-Mails: [email protected] (B.R.D.); [email protected] (M.A.R.); [email protected] (M.T.F.-L.) 2 Departments of Entomology, University of Georgia, Athens, GA 30602, USA; E-Mail: [email protected] 3 Department of Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30602, USA * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-515-294-1989; Fax: +1-515-294-2995. External Editor: Anne-Brit Kolstø Received: 2 May 2014; in revised form: 28 September 2014 / Accepted: 29 September 2014 / Published: 22 October 2014 Abstract: Insect-specific toxins derived from Bacillus thuringiensis (Bt) provide a valuable resource for pest suppression. Here we review the different strategies that have been employed to enhance toxicity against specific target species including those that have evolved resistance to Bt, or to modify the host range of Bt crystal (Cry) and cytolytic (Cyt) toxins. These strategies include toxin truncation, modification of protease cleavage sites, domain swapping, site-directed mutagenesis, peptide addition, and phage display screens for mutated toxins with enhanced activity. Toxin optimization provides a useful approach to extend the utility of these proteins for suppression of pests that exhibit low susceptibility to native Bt toxins, and to overcome field resistance.
    [Show full text]
  • Aflatoxin, Fumonisin and Shiga Toxin-Producing Escherichia Coli
    Toxins 2013, 5, 1872-1895; doi:10.3390/toxins5101872 OPEN ACCESS toxins ISSN 2072-6651 www.mdpi.com/journal/toxins Article Aflatoxin, Fumonisin and Shiga Toxin-Producing Escherichia coli Infections in Calves and the Effectiveness of Celmanax®/Dairyman’s Choice™ Applications to Eliminate Morbidity and Mortality Losses Danica Baines 1,*, Mark Sumarah 2, Gretchen Kuldau 3, Jean Juba 4, Alberto Mazza 5 and Luke Masson 5 1 Lethbridge Research Centre, Agriculture and Agri-Food Canada, 5403 1 Avenue South, Lethbridge, AB T1J 4B1, Canada 2 Southern Crop Protection and Food Research Centre, Agriculture and Agri-Food Canada, 1391 Sandford Street, London, ON N5V 4T3, Canada; E-Mail: [email protected] 3 PENNSTATE, 321 Buckhout Laboratory, University Park, PA 16802, USA; E-Mail: [email protected] 4 PENNSTATE, Fusarium Research Center, 216 Buckhout Laboratory, University Park, PA 16802, USA; E-Mail: [email protected] 5 National Research Council of Canada, Montréal, QC H4P 2R2, Canada; E-Mails: [email protected] (A.M.); [email protected] (L.M.) * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-403-320-8690; Fax: +1-403-382-3156. Received: 9 September 2013; in revised form: 8 October 2013 / Accepted: 11 October 2013 / Published: 23 October 2013 Abstract: Mycotoxin mixtures are associated with Shiga toxin-producing Escherichia coli (STEC) infections in mature cattle. STEC are considered commensal bacteria in mature cattle suggesting that mycotoxins provide a mechanism that converts this bacterium to an opportunistic pathogen. In this study, we assessed the mycotoxin content of hemorrhaged mucosa in dairy calves during natural disease outbreaks, compared the virulence genes of the STECs, evaluated the effect of the mucosal mycotoxins on STEC toxin expression and evaluated a Celmanax®/Dairyman’s Choice™ application to alleviate disease.
    [Show full text]
  • Fumonisin Content in Conventional Versus Bt Maize and Implications Of
    Iowa State University Capstones, Theses and Graduate Theses and Dissertations Dissertations 2013 Fumonisin content in conventional versus Bt maize and implications of fumonisin contamination on fuel ethanol yield and DDGS quality Erin Louise Bowers Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/etd Part of the Agriculture Commons, and the Toxicology Commons Recommended Citation Bowers, Erin Louise, "Fumonisin content in conventional versus Bt maize and implications of fumonisin contamination on fuel ethanol yield and DDGS quality" (2013). Graduate Theses and Dissertations. 13596. https://lib.dr.iastate.edu/etd/13596 This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. Fumonisin content in conventional versus Bt maize and implications of fumonisin contamination on fuel ethanol yield and DDGS quality by Erin Louise Bowers A dissertation submitted to the graduate faculty in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Major: Toxicology Program of Study Committee: Gary P. Munkvold, Major Professor Patricia A. Murphy Richard L. Hellmich Steve M. Ensley Lawrence A. Johnson Felicia Wu Anthony L. Pometto III Iowa State University Ames, Iowa 2013 Copyright
    [Show full text]
  • INVITED SPEAKERS (INV) Presentation: Monday, September 28, 2015 from 10:30 – 11:00 in Room Congress Saal
    INVITED SPEAKERS (INV) Presentation: Monday, September 28, 2015 from 10:30 – 11:00 in room Congress Saal. INV01 Redefining Virulence: Bacterial Gene Expression during INV03 Human Infection Breath-taking viral zoonosis: Lessons from influenza viruses H. L. T. Mobley T. Wolff University of Michigan Medical School, Department of Robert Koch-Institut, Division 17, Influenza viruses and other Microbiology and Immunology, Ann Arbor, United States Respiratory Viruses, Berlin, Germany Investigators identifying virulence genes at first did so by The World Health Organization recently expressed concerns about examining transposon mutants or individual gene mutations. an unprecedented diversity and geographical distribution of Mutants of bacterial pathogens were then assessed in animals, influenza viruses currently circulating in animal reservoirs. This whose symptoms mimicked human disease. Later, genome-wide includes an increase in the detection of animal influenza viruses screens (STM, IVET, IVIAT) were developed whereby genes and that co-circulate and exchange viral genes giving rise to novel virus proteins that influence virulence could be identified. These efforts strains. As the avian and porcine host reservoirs have in the past led to our conventional view of microbial virulence, with its focus contributed essentially to the genesis of human pandemic influenza on adhesins, iron acquisition, toxins, secretion, and motility, as viruses causing waves of severe respiratory disease on a global well as on those bacteria with genes such as on horizontally scale, this is a notable situation. transferred pathogenicity-associated islands that are not found in Zoonotic transmissions of avian influenza viruses belonging to the commensal strains. Now, however, we also must consider what H5N1 or H7N9 subtypes have been well documented in recent metabolic pathways are in play when microbial pathogens infect years.
    [Show full text]
  • | Hao Wanatha Maria Del Contatta Datum
    |HAO WANATHA MARIAUS009844679B2 DEL CONTATTA DATUM (12 ) United States Patent ( 10 ) Patent No. : US 9 ,844 , 679 B2 Nayfach - Battilana ( 45 ) Date of Patent : * Dec . 19 , 2017 (54 ) NANOPARTICLE - SIZED MAGNETIC (56 ) References Cited ABSORPTION ENHANCERS HAVING THREE - DIMENSIONAL GEOMETRIES U . S . PATENT DOCUMENTS ADAPTED FOR IMPROVED DIAGNOSTICS 4 , 106 ,488 A 8 / 1978 Gordon AND HYPERTHERMIC TREATMENT 4 ,303 ,636 A 12/ 1981 Gordon ( 71 ) Applicant: Qteris, Inc. , San Rafael, CA (US ) ( Continued ) ( 72 ) Inventor : Joseph N . Nayfach - Battilana , San FOREIGN PATENT DOCUMENTS Rafael , CA (US ) EP 0040512 B1 11 / 1981 EP 0136530 A16 /1988 (73 ) Assignee : Qteris, Inc. , San Rafael , CA (US ) (Continued ) ( * ) Notice : Subject to any disclaimer , the term of this patent is extended or adjusted under 35 OTHER PUBLICATIONS U . S . C . 154 ( b ) by 903 days. “ Krishna et al ., Unusual size -dependent magnetization in near This patent is subject to a terminal dis hemispherical Co nanomagnets on SiO . sub . 2 from fast pulsed laser claimer . processing” , J . Appl. Phys. 103 , 073902 (2008 ) (“ Krishna ” ) .* (Continued ) ( 21 ) Appl . No .: 14 /044 , 251 Primary Examiner — Joseph Stoklosa (22 ) Filed : Oct. 2 , 2013 Assistant Examiner — Adam Avigan (74 ) Attorney , Agent, or Firm — Marek Alboszta (65 ) Prior Publication Data US 2014 /0172049 A1 Jun . 19 , 2014 (57 ) ABSTRACT Nanoparticle- sized magnetic absorption enhancers (MAES ) Related U . S . Application Data exhibiting a controlled response to a magnetic field , includ ing a controlled mechanical response and an inductive (62 ) Division of application No . 12 /925 ,904 , filed on Nov. thermal response . The MAEs have a magnetic material that 1 , 2010 , now Pat .
    [Show full text]